SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer

Clinical trial NCT02545751 · UNKNOWN

Trial details

NCT number: NCT02545751
Sponsor: Hangzhou Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Metastatic Esophageal Cancer Stereotactic Body Radiation Therapy Thymalfasin

Start date: 2016-01-01
Primary completion: 2017-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.